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Vellore, a region in southern India, has a high inci-
dence of severe human infections with β-hemolytic group 
C and G streptococci (GCGS). To determine the causative 
species in these infections, we conducted 16S rRNA gene 
sequencing: Streptococcus dysgalactiae subsp. equisimilis 
(81%) and S. anginosus (19%) were the causative organ-
isms in the 2-year study period (2006–2007). We used PCR 
to detect the virulence-related emm gene; results showed 
that it was restricted to S. dysgalactieae subsp. equisimilis 
isolates of 99.2% tested positive. Due to a novel marker, 
S. anginosus and S. constellatus can be quickly and ac-
curately distinguished from other members of the genus. 
The notable contribution of the anginosus group to human 
infections suggests that this group of obligate pathogens 
deserves more attention in healthcare and research.
G
roup C and group G streptococci (together GCGS) 
were  ﬁ  rst recognized as human pathogens in 1935 
by Lanceﬁ  eld and Hare (1). Since then, awareness about 
their importance has greatly increased, especially within 
recent years (2–6). Similar to infections with Streptococ-
cus pyogenes, the prime example of a pyogenic streptococ-
cal pathogen, infections with GCGS can develop into life-
threatening necrotizing fasciitis, sepsis, and streptococcal 
toxic shock–like syndrome. Lanceﬁ  eld groups C and G 
comprise a variety of species; one of those species, Strepto-
coccus dysgalactiae subsp. equisimilis (SDSE), frequently 
causes human infections. This species can cause the whole 
spectrum of infections caused by S. pyogenes (4,5).
SDSE likely owes its virulence in humans to homologs 
of prominent S. pyogenes virulence genes (7,8). Most SDSE 
strains isolated from human infections possess emm genes 
(9,10), which code for the potent virulence factor called 
M protein (11). This surface localized protein contributes 
substantially toward the virulence of both S. pyogenes and 
SDSE in human hosts because it acts as an adhesin, invasin, 
and antiphagocytic factor (11). Strain-to-strain variability 
in the N terminus of M proteins, driven by the adaptive 
immune response of the host, has led to a vast emm type di-
versity. More than 100 genetically distinct M proteins exist 
within the GCGS group and form the basis for emm geno-
typing (12). However, SDSE is not the only species that 
causes severe diseases in humans. The variety of GCGS 
includes the typical animal pathogens S. equi subsp. zooep-
idemicus (group C) and S. canis (group G), which have the 
potential to cause zoonotic infections (13,14). Other strep-
tococcal species that are pathogenic in humans and that oc-
casionally expose groups C and G carbohydrates are gath-
ered under the umbrella term anginosus group (15).
In the literature, the designation S. milleri (16) has 
often been used for streptococci of this group, although it 
has never been an ofﬁ  cially approved name (15). Strepto-
cocci of the anginosus group can reside commensally in the 
human oral cavity but have a certain propensity to cause 
pharyngitis, bacteremia, and serious purulent infections in 
the deep neck and soft tissue and in internal organs such 
as the brain, lung, and liver (17–25). The bacteria cause 
severe infections after surgical treatments and infect im-
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planted material, thereby posing a problem of substantial 
clinical relevance (20,26,27). The species diversity within 
the GCGS highlights the limits of Lanceﬁ  eld grouping by 
agglutination assays, the typically applied method in the 
diagnosis of streptococcal infections. The genetically dis-
tinct GCGS species differ in pathogenesis, virulence mech-
anisms, and antimicrobial drug susceptibility. Thus, ﬁ  nding 
the optimal treatment regimen can be facilitated by species 
determination. Diagnosis of anginosus group infections is 
particularly difﬁ  cult. The group comprises the species S. 
anginosus, S. intermedius, and S. constellatus of which the 
2 subspecies, S. constellatus subsp. constellatus and S. con-
stellatus subsp. pharyngis, are further distinguished. Iden-
tiﬁ  cation of the anginosus group is complicated by wide 
phenotypic and antigenic diversity, even within 1 species. 
Although most anginosus group isolates belong to the 
non-β-hemolytic oral streptococci, β-hemolytic strains are 
found in all 3 species. Some anginosus group strains carry a 
typeable Lanceﬁ  eld group antigen, which belongs to group 
F, C, G, or A (28).
Routine microbiologic diagnosis of streptococcal in-
fections is often restricted to determination of the type of 
hemolysis and of the Lanceﬁ  eld group. Identiﬁ  cation of 
streptococci to the species level is rarely carried out. This 
leaves a considerable risk for misidentiﬁ  cation of caus-
ative pathogens, which can lead to an inappropriate treat-
ment of the infection (29–31). As a further consequence 
of the complications associated with species determination, 
insight into the epidemiology of infections with certain 
streptococci remains imprecise, and the epidemiology of 
the anginosus group, in particular, remains widely elusive. 
Comprehensive insights are missing that could enable cli-
nicians to reevaluate respective diagnostic and therapeutic 
routines. Moreover, such insights may stimulate research 
that aims at clarifying the pathogenesis of these streptococ-
cal species and the development of specialized treatments 
and prevention strategies. These goals have motivated our 
cross-species study of human pathogenic GCGS from Vel-
lore, India, a region with a high incidence of such infec-
tions. Examination of epidemiologic contributions of the 
different streptococcal species was combined with a cross-
species screening for emm genes, which identiﬁ  ed a novel 
gene in S. anginosus and S. constellatus. The use of this 
gene as a marker for fast detection of infections caused by 
these 2 streptococcal species was investigated.
Methods
Bacterial Strains, Lanceﬁ  eld Typing, 
and Genomic DNA 
Clinical isolates of group G and group C streptococci 
were collected at the Department of Clinical Microbiol-
ogy, Christian Medical College, Vellore, India, from 2006 
through 2007. The collection comprised isolates from pa-
tients with pharyngitis (throat swabs), patients with respira-
tory (sputum) and urinary tract infections (urine), and from 
other suppurative foci (pus) and blood. Streptococci were 
collected from 2004 through 2006 at the University Hospi-
tal in Leipzig, Germany. The isolates were recovered from 
blood cultures, wound swabs, aspirates of peritonsillar ab-
scesses, abscesses in the inner body, and catheter tips. The 
collection was typed as described previously (32). Bacterial 
strains were subcultured on Columbia agar with 5% sheep 
blood (Becton-Dickinson, Franklin Lakes, NJ, USA). Cul-
tures from single colonies were grown overnight (37°C in 
5% CO2) in Todd-Hewitt broth (Becton-Dickinson) supple-
mented with 0.5% yeast extract. The Lanceﬁ  eld group was 
determined by using the Slidex streptococcal grouping kit 
(Oxoid, Basingstoke, UK). Genomic DNA was isolated by 
using the DNeasy Blood and Tissue Kit (QIAGEN, Hilden, 
Germany) according to the manufacturer’s protocol with 
a minor variation: the incubation with proteinase K was 
carried out at 70°C for 30 min.
Sequencing of emm and 16S rRNA Genes
Ampliﬁ  cation of emm genes from streptococcal ge-
nomic DNA samples was performed by using the primers 
1 and 2 recommended by the Centers for Disease Control 
and Prevention (12) (emm-PCR). To amplify the 16S rRNA 
gene, PCR was performed with a pair of generic primers: 
16S rDNA fwd and 16S rDNA rev (Table 1), for gram-
positive bacteria as described (33). PCR experiments were 
analyzed by agarose (1%) gel electrophoresis. PCR prod-
ucts were puriﬁ  ed by using the QIAGEN PCR puriﬁ  cation 
Kit (QIAGEN, Hilden, Germany) and sequenced by using 
primer 16S rDNA fwd (Table 1), the Big Dye Terminator 
reaction, and an ABI Prism 377 system (Applied Biosys-
tems, Foster City, CA, USA).
Inverse PCR and Sequencing of a Marker 
of S. anginosus and S. constellatus
Application of emm-PCR on the genomic DNA of S. 
anginosus strain SV52 produced a 1.1-kb amplicon, sub-
sequently identiﬁ  ed as a fragment of a marker of S. an-
ginosus and S. constellatus ( moac). The fragment was 
cloned into the pCR2.1-TOPO vector by using the TOPO 
TA cloning kit (Invitrogen, Carlsbad, CA, USA) and 
then sequenced by using primers M13 rev and M13 fwd 
(Table 1). Inverse PCR was used to amplify the genomic 
DNA segments ﬂ  anking the 1.1-kb fragment of moac. Ge-
nomic DNA (1 μg) was digested separately with 1–3 of 
the following enzymes: AseI, AvrII, BamHI, BglII, BsaI, 
BseYI, EcoRI, HindIII, NdeI, NsiI, PstI, SacI, SalI, SpeI, 
XbaI, XhoI (New England Biolabs, Ipswich, MA, USA). 
Digestion was carried out for 16 h under conditions rec-
ommended by the manufacturer. Digested genomic DNA 
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was diluted both 100-fold and 10-fold before self-ligation 
with 160 U ligase (16 h, 16°C). Afterwards the ligations 
were used as a template in PCR experiments with different 
combinations of the primers moac1 to moac14 (Table 1). 
PCR was performed in a thermocycler (Biometra GmbH, 
Goettingen, Germany) with an initial denaturation step (4 
min at 96°C), followed by 30 cycles of denaturation (40 s 
at 94°C), annealing (30 s at 56°C), and extension (1 min, 30 
s, up to 3 min, 72°C). A ﬁ  nal extension was carried out for 
5 min at 72°C. PCR products were analyzed, puriﬁ  ed, and 
sequenced as described above.
Screening for moac
Isolated genomic DNA was tested by PCR for the 
presence of the moac gene. For this purpose, 2 primer 
pairs (Table 1) were used to amplify a 3,272-bp fragment 
(primers: moac-SP, moac-TMH7) and a 962-bp internal 
fragment (primers: moac-BamHI,  moac-SalI) of moac, 
respectively. For ampliﬁ  cation of the 962-bp fragment, 
initial denaturation (4 min at 96°C) was followed by 25 
cycles of denaturation (40 s at 94°C), annealing (30 s at 
53°C), and extension (1 min 30 s at 72°C), and then by 
a ﬁ  nal extension step for 5 min at 72°C. The 3,272-bp 
fragment was ampliﬁ  ed with 30 cycles by using an an-
nealing temperature of 50°C and an extension time of 3 
min, 20 s. The PCR products were analyzed, puriﬁ  ed, and 
sequenced as described above.
Sequence Analysis
Sequence data were processed and analyzed by using 
the software BioEdit version 7.0.1 (Isis Pharmaceuticals, 
Carlsbad, CA, USA). Coiled coil structures and transmem-
brane helixes were predicted with the Web-based programs 
Coils (34) and TMHMM Server v. 2.0 (35), respectively.
Results
Typing of GCGS Isolates and Screening 
for emm (-like) Genes 
The Vellore region in India has a high incidence of 
group C and G streptococcal infections (36). For charac-
terization of local pathogenic GCGS strains, 313 isolates 
were collected from patients with suppurative or invasive 
infections at the Christian Medical College. The study was 
designed to be cross-species; therefore, the only preselec-
tion criteria applied were type of hemolysis and Lanceﬁ  eld 
type. Sequencing showed that 254 of the strains showed 
highest homology with the 16S rRNA gene from SDSE and 
that the sequences of the remaining 59 strains were homol-
ogous to S. anginosus (Table 2). Notably, all S. anginosus 
strains belonged to Lanceﬁ  eld group G. M proteins have 
a fundamental role in streptococcal infections. Therefore, 
and because of a potential power to discriminate between 
SDSE and anginosus group strains, the collection was ex-
amined by emm-PCR (12) (Table 2). Speciﬁ  c PCR prod-
ucts were obtained for 252 of the 313 stains. Two of the 
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Table 1. Sequences of primers used in study of groups C and G streptococci, Vellore, India, and Leipzig, Germany* 
Name Sequence  (5ƍ o 3ƍ) Application 
16S rDNA fwd  AGAGTTTGATCCTGGCTC 16S rDNA amplification 
16S rDNA rev  GGTTACCTTGTTACGACTT
Primer 1  TATTCGCTTAGAAAATTAA  emm amplification 
Primer 2  GCAAGTTCTTCAGCTTGTTT 
M13 rev  CAATTTCACACAGGAAACAGCTATGAC Sequencing of 1.1-kb fragment of moac 
M13 fwd  GTAAAACGACGGCCAGTGAATTG
moac1  CAAGGAATTGATTCAGCAACAGTGC Inverse PCR and sequencing of moac 
moac3 CTTCTCAACAAGCATTGGCAGATGC
moac6 GTGTGTATACACGTCGGACATTTCC
moac7 GGTACAGTAATGGGAAGTTTGTTAGG 
moac8 GCGGATTGACTTCATTTGGCGTCG
moac9 GGTTTGGGGATGTCTTCTTCCATGG
moac10 GCATCTCAAATCAGACGAGCAAGC
moac11 CTTGAACTTGTCTTCGCATGGAGC
moac12 GACTATTATCAAACGGTATTTGCTCG
moac2 CCAATTCACTTGAATTGACGAATCC
moac4 GCCCAACCTGAAGACAGTTGAGC
moac5 CTGACGAAAAGAGAGCCAGATATCC
moac13 CTGATACCATAATCTGACATCACTGC
moac14 GAAGTTGAACTATCTCCAATCACCG
moac-SP  ATGAAAAAATCCATTCTAAATAAGGATATC Screening for 3,272-bp fragment of moac 
moac-TMH7 AAGACTGGCACAAGATATAC
moac-BamH1  GCGGATCCGGTCATTTTCCAAGCAAGG Screening for 962-bp fragment of moac 
moac-Sal1 GCTGTCGACTTATTAAATTCAGCCTGCTTTTTCTCC
*moac, marker of Streptococcus anginosus and S. constellatus. Streptococcus anginosus, Southern India
SDSE strains and the 59 anginosus group strains were not 
emm-typeable. The SDSE strains comprised 44 different 
emm types, of which 2, stG120 and stG351, have not been 
previously described (Table 3).
Characteristics of a Newly Discovered 
Open Reading Frame of S. anginosus
Our recent survey at the University Hospital in Leipzig, 
comprising 127 cases of severe infections with oral strepto-
cocci, found that a large number of infections were caused 
by strains that belonged to the anginosus group (26%). We 
included the anginosus group strains from the Leipzig col-
lection in the emm-typing experiments described above to 
increase the number of isolates and the phenotypic diversity 
of the collection in terms of Lanceﬁ  eld antigen and type of 
hemolysis. Like the S. anginosus strains from Vellore, none 
of the 33 strains from Leipzig was emm-typeable. Under 
less stringent conditions, the PCR produced a low concen-
tration amplicon of 1.1 kb (Figure). 
Sequencing of the of 1.1-kb PCR product did not show 
considerable similarities with emm-genes, however, the lack 
of stop codons in 1 frame of translation motivated further in-
vestigations on that PCR product. Inverted PCR experiments 
on S. anginosus strain SV52 identiﬁ  ed an open reading frame 
(ORF) of 3,363-bp (GenBank accession no. GQ456155). 
Computational analysis predicts a 124-kDa membrane pro-
tein with 7 transmembrane sequences and a signal peptide 
for secretion (Figure). The predicted protein further consists 
of 2 larger extracellular regions, one of 23 kDa located be-
tween the fourth and ﬁ  fth transmembrane sequence and one 
of 60 kDa at its N terminal end. The central part of the N 
terminal extracellular region contains a stretch of heptad-
repeats (aa 204 to 520 of the mature protein), which may en-
able coiled-coil oligomerization. Other than this, the protein 
has no obvious or signiﬁ  cant features of an M- or M-related 
protein. Prediction of 7 transmembrane sequences suggests 
a receptor function or a function in transport processes. The 
latter assumption is corroborated by a high similarity of the 
protein sequence to numerous bacterial permease compo-
nents of ATP-binding cassette transporters.
Distinguishing of S. anginosus and S. constellatus 
from Other Oral Streptococci by a Newly 
Discovered ORF
The distribution of the newly discovered ORF in the 
Leipzig collection of oral streptococci was examined by 
PCR with 2 different primer pairs (Table 1). Both primer 
combinations gave identical results. The collection consists 
of 127 clinical isolates of which 33 belong to the anginosus 
group (17 S. anginosus, 8 S. constellatus subsp. constel-
latus, 4 S. constellatus subsp. pharyngis, 4 S. intermedius); 
78 belong to species of the mitis group (S. mitis, S. oralis, 
S. sanguinis, S. parasanguinis). Fourteen strains have been 
typed as S. salivarius and 2 as S. gallolyticus. Speciﬁ  c PCR 
products were obtained exclusively within the anginosus 
group. All S. anginosus and S. constellatus isolates tested 
positive. Negative PCR distinguished S. intermedius from 
the other 2 species. The results were conﬁ  rmed in experi-
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Table 2. Typing of groups C and G streptococci collection, Vellore, India 
Species (N = 313)  16S rRNA gene 
emm-PCR 
positive/negative
moac-PCR* 
positive/negative
Lancefield group 
GC
S. dysgalactiae subsp. equisimilis 254 252/2 0/254  208 46
S. anginosus 59 0/59 59/0 59 0
*Tested with 2 primer pairs (Figure). moac, marker of Streptococcus anginosus and S. constellatus.
Figure. Ampliﬁ   cation and characterization of a newly discovered open reading frame (ORF) of Streptococcus anginosus.  A) Gel 
electrophoresis after emm-PCR on S. anginosus isolate SV52 (SV52) and S. pyogenes strain A60 (A60). The latter isolate was used as 
a control that possesses an emm3 gene. The S. anginosus strain generated a low concentration 1.1-kb amplicon, as compared with the 
1.4-kb product of the S. pyogenes strain. Inverse PCR based on the 1.1-kb sequence of SV52 showed an ORF of 3,363 bp. Its sequence is 
predicted to code for the membrane protein that is schematically depicted in panel B. It comprises an N terminal signal peptide (S) followed 
by a large extracellular region of 60 kDa (ECR1), 7 transmembrane helixes (1–7), and another large extracellular region of 23 kDa situated 
between the fourth and the ﬁ  fth transmembrane helix (ECR3). Positions of the 2 alternative marker of Streptococcus anginosus and S. 
constellatus PCR products (I and II) relative to the full-length sequence and their length are indicated in basepairs.RESEARCH
ments with reference strains from the Deutsche Sammlung 
für Mikroorganismen und Zellkulturen (Table 4). Taken 
together, the results demonstrate that the newly discovered 
gene is a marker that discriminates S. anginosus and S. con-
stellatus from other oral streptococci. The gene was there-
fore designated moac.
Moac as a Marker for S. anginosus within GCGS
The data that were obtained with the Leipzig collec-
tion of oral streptococci suggested that moac could also be 
exploited as a marker for β-hemolytic strains of the angi-
nosus group. To further test the quality of moac as a mark-
er, the Vellore GCGS collection was subjected to moac-
speciﬁ  c PCR (moac-PCR). The results are summarized in 
Table 2. All 254 strains that were speciﬁ  ed as SDSE on 
the basis of their 16S rRNA gene sequence were negative 
in moac-PCR. The 59 remaining strains, which could be 
assigned to the species S. anginosus by 16S rRNA gene 
sequencing, were positive for moac. Moreover, strains 
of the species S. canis (2), S. equi subsp. zooepidemicus 
(3), S. equi subsp. equi (2), and S. dysgalactiae subsp. 
dysgalactiae (2) were negative in the moac-PCR, proving 
that it is a reliable method for identifying anginosus group 
strains in collections of GCGS. The examination showed 
that S. anginosus isolates constitute 19% of the collection 
of β-hemolytic GCGS isolates from clinical suppurative 
infections in Vellore; thus, these pathogens play a con-
siderable epidemiologic role in acute streptococcal infec-
tions that occur in this region.
Discussion
Lanceﬁ  eld groups C and G comprise a variety of 
distinct species; of these species, S. dysgalactiae subsp. 
equisimilis, S. equi subsp. zooepidemicus, S. canis, and 
streptococci of the anginosus group cause severe infec-
tions in humans (2–5, 17–27). Examination of clinical 
isolates from patients with purulent infections of the up-
per respiratory tract, the urinary tract, and invasive infec-
tions showed that SDSE is dominant in GCGS infections 
in Vellore, accounting for 81% of the cases. SDSE was 
responsible for all 7 cases of invasive infections included 
in this study. S. anginosus that possess group G antigens 
accounted for the remaining 19% of the suppurative in-
fections, which indicates a considerable epidemiologic 
role for this species in the Vellore region. In contrast, 
β-hemolytic group C streptococci of the pharyngitis-
associated species S. constellatus subsp. pharyngis (37) 
were not detected. Infections with the typically zoonotic 
β-hemolytic GCGS S. equi subsp. zooepidemicus (group 
C) and S. canis (group G) were also not diagnosed, which 
suggests a comparatively low incidence of such infections 
in Vellore. Groups C and G antigens are rare in S. con-
stellatus subsp. constellatus and in S. intermedius (28), if 
they are present at all in these species. Their absence in 
the Vellore GCGS collection, therefore, cannot be con-
sidered as indicative that these species have less clinical 
relevance.
The high phenotypic and antigenic diversity within the 
anginosus group, and the circumstance that non–β-hemolytic 
strains remain inconspicuous in samples that contain com-
mensal ﬂ  ora, make anginosus group infections difﬁ  cult to 
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Table 3. emm typing of pathogenic Streptococcus dysgalactiae 
subsp. equisimilis isolates from Vellore, India* 
emm type No.  strains 
stG245 32 
stG6792 18 
stG643 17 
stG6 14 
stG653 14 
stC1400 12 
stGL265 12 
stG652 11 
stG866 10 
stC5345 9 
stG485 9 
stC74a 9 
stC6979 8 
stC839 7 
stGLP1 7 
stGrobn 5 
stC922 4 
stG211 4 
stC2sk 3 
stG2574 3 
stG4222 3 
stG480 3 
stG4831 3 
stG5420 3 
stG7882 3 
stG120* 3 
emm31 2 
stC36 2 
stCK401 2 
stG166b 2 
stG2078 2 
stG840 2 
stG97 2 
stG10 2 
stG351* 1 
emm23 1 
stC1741 1 
stC3852 1 
stC46 1 
stC5344 1 
stC6746 1 
stC-NSRT2 1 
stGM220 1 
stMD216 1 
*The 5ƍ sequences of newly identified emm genes are deposited in 
GenBank (accession nos. FJ036933, FJ036936, and FJ036937) and in the 
emm-gene database of the Centers for Disease Control and Prevention, 
Atlanta, GA, USA. Streptococcus anginosus, Southern India
diagnose. Therefore, contribution of the anginosus group as 
a whole to the epidemiology of streptococcal infections is 
poorly understood and needs further investigation, not only 
in Vellore but also in other regions with suspected high in-
cidence. The required surveys will become feasible with the 
identiﬁ  cation of potent markers for detection of anginosus 
strains such as the moac marker. The isolates from Vellore 
and Leipzig together represent a highly diverse collection of 
anginosus strains that differ not only in their geographic ori-
gin, but greatly in Lanceﬁ  eld type. The collection comprises 
strains with groups A, C, G, and F, and without Lanceﬁ  eld 
antigen. Furthermore, the collection includes isolates with 
all types of hemolysis. The diagnostic power of moac is 
demonstrated by the herein described PCR test that identi-
ﬁ  ed all of the phenotypically diverse S. anginosus and S. 
constellatus strains, discriminating them from other strep-
tococci with 100% accuracy. To the best of our knowledge, 
this PCR method is the only one described that distinguishes 
S. constellatus subsp. pharyngis and S. intermedius. In ad-
dition to the reliability, the use of the moac as a marker may 
have a further valuable advantage; the moac gene is pre-
dicted to code for a transmembrane protein, a property that 
could be exploited for the development of an antibody based 
test for species determination.
Further valuable diagnostic information may lie in the 
emm gene. Examination of the Vellore collection allowed 
assessment of emm typing for use in species determination. 
Most of the 254 SDSE strains included in this study were 
positive for the emm gene by PCR. However, 2 strains of 
this species were negative for it, indicating that a negative 
emm-PCR is not an accurate exclusion criterion in typing 
of SDSE. In contrast to SDSE strains, all anginosus group 
strains, from both the Vellore and the Leipzig collection, 
were negative in emm-PCR. This examination of pheno-
typically diverse strains strongly suggests that a negative 
result from emm-PCR is a common, if not a general, prop-
erty of the anginosus group. Oligonucleotide hybridization 
experiments did not show any indications for the pres-
ence of emm-homologs in such isolates (data not shown). 
Moreover, and contrary to observations with S. equi subsp. 
zooepidemicus and S. equi subsp. equi, binding experi-
ments with plasma proteins suggest that anginosus strains 
lack surface proteins that exert the typical functions of M 
proteins (data not shown).
Despite the absence of this key virulence factor, the 
anginosus group includes opportunistic pathogens that can 
cause bacteremia and a variety of severe purulent infec-
tions in the oral cavity, the urogenital tract, and internal 
organs. This circumstance raises the question, what are the 
factors that allow streptococci of the anginosus group to 
colonize at the site of infection and to survive under the 
hostile conditions of the suppurative focus of infection and 
the bloodstream? Little is known about the pathogenesis of 
anginosus group infections, but they seem to be governed 
by unique, unknown mechanisms. Unique mechanisms of 
pathogenesis and the decreased susceptibility of angino-
sus group strains to certain antimicrobial drugs (15) create 
a need for well-tailored treatments and thus for accurate 
diagnosis. In this context, indications that treatment with 
metronidazole facilitates infections with streptococci of the 
anginosus group deserve particular attention (26,38–40). 
Accumulating indications of the considerable clinical rel-
evance of the anginosus group and the propensity of these 
bacteria to develop antimicrobial drug resistance suggest 
that they may be a group of emerging pathogens that should 
be monitored.
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Table 4. Distribution of moac within a collection of oral 
streptococci, Vellore, India, and Leipzig, Germany* 
Group/species 
No.
strains  moac-PCR 
Anginosus group  33
 Streptococcus  anginosus 17 +
 S.  constellatus subsp. constellatus 8+
 S.  constellatus subsp. pharyngis 4+
 S.  intermedius 4–
Bovis group  2
 S.  gallolyticus 2–
Mitis group  78
 S.  gordonii 5–
  S. mitis/S. oralis 12 –
 S.  mitis 12 –
 S.  oralis 24 –
 S.  parasanguinis 18 –
 S.  sanguinis 7–
Salivarius group  14
 S.  salivarius 14 –
Reference strains (DSMZ) 
 Anginosus  group  4
  S.  anginosus 1+
  S.  constellatus subsp. constellatus 1+
  S.  constellatus subsp. pharyngis 1+
  S.  intermedius 1–
 Mutans  group  1
  S .   m u t a n s 1–
*moac, marker of Streptococcus anginosus and S. constellatus; DSMZ, 
Deutsche Sammlung für Mikroorganismen und Zellkulturen. RESEARCH
Dr Reißmann is a biologist at the Helmholtz-Centre for In-
fection Research. She conducts research on streptococcal patho-
gens, developing new diagnostics approaches and investigating 
their mechanisms of pathogenesis.
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